Parvovirus B19 in pregnancy: Literature review;Parvovirus B19 et grossesse : revue de la littérature

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 11, 2007, Pages 1095-1104

  Morel, O ^a   Chagnaud, S ^a   Laperrelle, J ^a   Clement D ^a   Malartic, C ^a   Akerman, G ^a   Tulpin, L ^a   Sitbon, M ^a   Barranger, E ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Fetal anemia; Intrauterine infection; Intrauterine transfusion; Parvovirus B19

Indexed keywords

VIRUS DNA;

ANEMIA; ARTICLE; CORDOCENTESIS; DIFFERENTIAL DIAGNOSIS; ERYTHEMA INFECTIOSUM; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS HYDROPS; FETUS OUTCOME; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; MIDDLE CEREBRAL ARTERY; MYOCARDITIS; NONHUMAN; PARVOVIRUS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIMARY INFECTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VIRUS MORPHOLOGY; VIRUS TRANSMISSION; ADULT; FEMALE; INTRAUTERINE BLOOD TRANSFUSION; ISOLATION AND PURIFICATION; METHODOLOGY; NEWBORN; NEWBORN ANEMIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; VIROLOGY; VIRUS INFECTION;

ADULT; ANEMIA, NEONATAL; BLOOD TRANSFUSION, INTRAUTERINE; DNA, VIRAL; FEMALE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 36549074154     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.07.036     Document Type: Article

References (75)

1. Cossart Y., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. Pattison J.R., Jones S.E., Hodgson J., et al. Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet 1 (1981) 664-665
3. Centre for Disease Control. Risks associated with human parvovirus B19 infection. MMWR CDC Surveill Summ 38 (1989) 81-95
4. Anderson M.J., Jones S.E., Fisher-Hosh S.P., et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet 1 (1983) 1378
5. Knott P.D., Welply G.A., and Anderson M.J. Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed). 289 6459 (1984) 1660
6. Brown T., Anand A., Ritchie L.D., Clewley J.P., and Reid T.M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2 (1984) 1033-1034
7. Belshe R.B. Parvoviruses. Textbook Hum Virol (1984) 58-62
8. Morinet F. Physiopathologie moléculaire de l'infection humaine à parvovirus B19. Approches moléculaires des maladies, FRISON-ROCHE 1992; 233-9.
9. Anderson LJ, Young N. Human parvovirus B19. In: Lennette EH, editor. Laboratory diagnosis of viral infections II. 1992.p. 627-38
10. Beersma M.F., Claas E.C., Sopaheluakan T., and Kroes A.C. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol 34 (2005) 71-75
11. Anderson M.J., and Cohen B.J. Human parvovirus B19 infection in United-Kingdom1984-86. Lancet 1 (1987) 738-739
12. Serjeant G.R., Serjeant B.E., Thomas P.W., Anderson M.J., Patou G., and Pattison J.R. Human parvovirus infection in homozygous sickle cell disease. Lancet 341 (1993) 1237-1240
13. Poissonier M.H., and Parvovirus B19. Infections virales en obstétrique (2001), Masson p. 61-7
14. Anderson M.J., Higgins P.G., Davis L.R., et al. Experimental parvoviral infection in humans. J Infect Dis 152 (1985) 257-265
15. Anderson L.J. Human parvoviruses. J Infect Dis 161 (1990) 603-608
16. Rodis J.F., Hovick T.J., Quinn D.L., Rosengren S.S., and Tattersall P. Human parvovirus infection in pregnancy. Obstet Gynecol 72 (1988) 733-738
17. Bond P.R., Caul E.O., Usher J., Cohen B.J., Clewley J.P., and Field A.M. Intrauterine infection with human parvovirus. Lancet 1 (1986) 448-449
18. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., and Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 357 (2001) 1494-1497
19. Leads from the Morbidity and Mortality Report. Risks associated with human parvovirus B19 infection. JAMA 1989: 261; 1406-8
20. Miller E., Fairley C.K., Cohen B.J., and Seng C. Immediate and long term outcome of human parvovirus infection in pregnancy. Br J Obstet Gynaecol 105 (1998) 174-178
21. Jordan J.A. Identification of human parvovirus B19 in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 174 (1996) 37-42
22. Valeur-Jansen A.K., Pedersen C.B., Westergaard T., et al. Risk factors for parvovirus infection in pregnancy. JAMA 281 (1999) 1099-1105
23. Enders M., Weidner A., Zoellner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human parvovirus B19 in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24 (2004) 513-518
24. De Hann T., Beersma M.F.C., Oepkes D., de Jong E.P., Kroes A.C.M., and Walther F.J. Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn 27 (2007) 46-50
25. Harger J.H., Adler S.P., Koch W.C., and Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: riks and symptoms. Obstet Gynecol 91 (1998) 413-420
26. Gray E.S., Davidson R.J.L., and Anand A. Human parvovirus and fetal anaemia. Lancet 1 (1987) 1144
27. Porter H.J., Quantrill A.M., and Fleming K.A. B19 parvovirus infection of myocardial cells. Lancet (1988) 535-536
28. Schild R.L., Bald R., Plath H., Eis-Hubingen A.M., Enders G., and Hansmann M. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 13 (1999) 161-166
29. Teixeira J.M.A., Duncan K., Letsky E., and Fisk N.M. Middle cerebral artery peak systolic velocity in the prediction of fetal anaemia. Ultrasound Obstet Gynecol 15 (2000) 205-208
30. Dickinson J.E., Keil A.D., and Charles A.K. Discordant fetal infection for parvovirus B19 in a dichorionic twin pregnancy. Twin Res Hum Genet 9 (2006) 456-459
31. Rogers B.B., Singer D.B., Mak S.K., Gary G.W., Fikrig M.K., and McMillan P.N. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, and the polymerase chain reaction. Obstet Gynecol 81 (1993) 402-408
32. Morey A.L., Keeling J.W., Porter H.J., and Fleming K.A. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 99 (1992) 556-574
33. Petrikovsky B.M., Baker D., and Schneider E. Fetal hydrops secondary to human parvovirus B19 infection in early pregnancy. Prenat Diagn 16 (1996) 342-344
34. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., and Broliden K. Human parvovirus B19 and fetal death-correspondance. Lancet 358 (2001) 1180
35. Nyman M., Tolfvenstam T., Petersson K., Krassny C., Skjöldebrand-Sparre L., and Brolinden K. Detection of human parvovirus B19 infection in first trimester fetal loss. Obstet Gynecol 99 (2002) 795-798
36. Kempe A., Rosing B., Berg C., et al. First trimester treatment of fetal anemia secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol 29 (2007) 226-228
37. Gallot D, Boiret N, Vanlieferinghen P, Laurichesse H, Micorek JC, Berger M, Lemery D. The peritoneal route as a safe pathway for early in utero therapies: illustration by a 12-year follow-up after conservative management of severe Rhesus allo-immunisation. Fetal Diagn Ther 2004.
38. Skjöldebrand-Sparre L., Nyman M., Brolinden K., and Wahren B. All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid. Am J Obstet Gynecol 180 (1999) 1595-1596
39. Manaresi E., Gallinella G., Zuffi E., Bonvicini F., Zerbini M., and Musiani M. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 67 (2002) 275-281
40. Enders M., Schalasta G., Baisch C., et al. Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. J Clin Virol 35 (2006) 400-406
41. Carrington D., Gilmore D.H., Whittle M.J., et al. Maternal serum alphafetoprotein, a marker of fetal aplastic crisis during intrauterine human parvovirus B19 infection. Lancet 1 (1987) 433-435
42. Bernstein I.M., and Capeless I.L. Elevated maternal serum alpha-foetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection. Obstet Gynecol 74 (1989) 456-457
43. Mari G., Moise K.J., Deter R.L., and Carpenter R.J. Flow velocity waveforms of the umbilical and cerebral arteries before and after intravascular transfusion. J Obstet Gynaecol 75 (1990) 584-589
44. Mari G., Moise K.J., Deter R.L., Kirshon B., Stefos T., and Carpenter R.J. Flow velocity waveforms of the vascular system in the anemic fetus before and after intravascular transfusion for severe red blood cell alloimmunization. Am J Obstet Gynecol 162 (1990) 1060-1064
45. Schwarz T.F., Roggendorf M., Hottenträger B., et al. Human parvovirus B19 infection in pregnancy. Lancet 2 (1988) 566-567
46. Delle Chiaie L., Buck G., Grab D., and Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood groop alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 232-236
47. Morrow R.J. Acute hypoxemia does not affect the umbilical artery flow velocity waveforms in fetal sheep. Obstet Gynecol 75 (1990) 590-593
48. Cosmi E., Mari G., Delle Chiaie L., et al. Non-invasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 187 (2002) 1290-1293
49. Mari G., Zimmermann R., Moise Jr. K.J., and Deter R.L. Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions. Am J Obstet Gynecol 193 (2005) 1117-1120
50. Imbar T., Lev-Sagie A., Cohen S., Yanai N., and Yagel S. Diagnosis, surveillance, and treatment of the anemic fetus using middle cerebral artery peak systolic velocity measurement. Prenat Diagn 26 (2006) 45-51
51. Mulliez N, Moirot H, Gonzales M, Roume J, Migne G. Anasarque fœtoplacentaire en dehors de l'iso-immunisation : physiopathogénie et épidémiologie. In: Vigot LF, editor. Diagnostic et prise en charge des affections fœtales III. 1989.
52. Morey A.L., Nicolini U., Welch C.R., Economides D., Chamberlain P.F., and Cohen B.J. Parvovirus infection and transient fetal hydrops. Lancet 1 (1991) 496
53. Grangeot-Keros L., and Cointe D. Infections virales et grossesse : apport des prélèvements amniotiques et sanguins. Gynecol Obstet Fertil 29 (2001) 894-899
54. Skjöldebrand-Sparre L., Tolfvenstam T., Papadogiannakis N., Wahren B., Broliden K., and Nyman M. Parvovirus B19 infection: association with third trimester intrauterine fetal death. Br J Obstet Gynaecol 107 (2000) 476-480
55. Forestier F., Tissot J.D., Vial Y., Daffos F., and Hohlfeld P. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 104 (1999) 925-927
56. Ergaz Z., and Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol 21 (2006) 421-435
57. Weiland H.T., Vermey-Keers C., Salimans M.M.M., Fleuren G.J., and Verwey R.A. Parvovirus B19 associated with fetal abnormality. Lancet 1 (1987) 682-683
58. Schild R.L., Plath H., Thomas P., Schulte-Wissermann H., Eis-Hübinger A.M., and Hansmann M. Fetal parvovirus B19 infection and meconium peritonitis. Fetal Diagn Ther 13 (1998) 15-18
59. Brown K.E. What threat is human parvovirus B19 to the fetus?. Br J Obstet Gynaecol 96 (1989) 764-767
60. Schild R.L., and Hansmann M. Small bowel atresia: antenatal intestinal vascular accident or parvovirus B19 infection?. Ultrasound Obstet Gynecol 11 (1998) 227
61. Jouannic J.M., Gavard L., Crequat J., Muller F., Serero S., Benifla J.L., et al. Isolated fetal hyperechogenic bowel associated with intra-uterine parvovirus B19 infection. Fetal Diagn Ther 20 (2005) 498-500
62. Stepan H., and Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 354 (2006) 1857-1858
63. Sillis M., White P.M.B., and Cohen B.J. Contact with rashes during pregnancy. Lancet 343 (1994) 1439
64. Peters N.T., and Nicolaides K.H. Cordocentesis for the diagnostis and treatment of human fetal parvovirus infection. Obstet Gynecol 75 (1990) 501-504
65. Smoleniec J.S., and Pillai M. Management of fetal hydrops associated with parvovirus B19. Br J Obstet Gynaecol 101 (1994) 1079-1081
66. Fairley C.K., Smoleniec J.S., Caul O.E., and Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 46 (1995) 1335-1337
67. Weiner C.P., Williamson R.A., Wenstrom K.D., et al. Management of fetal haemolytic disease by cordocentesis. Outcome of treatment. Am J Obstet Gynecol 165 (1991) 1302-1307
68. Grab D., Paulus W., Bommer A., Buck G., and Terinde R. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at six years. Obstet Gynecol 93 (1999) 165-168
69. Doyle L.W., Kelly E.A., Richards A.L., Ford G.W., and Callanan C. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol 81 (1993) 931-935
70. o°119.
71. Von Kaisberg Cs, and Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 280-288
72. Nagel H.T., de Haan T.R., Vandenbussche F.P., Oepkes D., and Walther F.J. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 109 (2007) 42-47
73. Pryde P.G., Nugent C.E., Pridjian G., Barr M., and Faix R.G. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol 79 (1992) 859-861
74. Sheikh A.U., Ernest J.M., and O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 167 (1992) 337-341
75. Matsuda H., Sakaguchi K., Shibasaki T., Takahashi H., Kawakami Y., and Furuya K. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med 33 (2005) 561-563